Clinical trial
Phase II Study to Evaluate the Effectiviness of copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy
NCT06708702 is registered in ClinicalTrials.gov with Instituto Nacional de Cancer, Brazil as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study to Evaluate the Effectiviness of copaíba-based Mouthwash in Oral Mucotitis Prevention and Treatment in Oral Cancer Patients During Radioteraphy
- Lead sponsor
- Instituto Nacional de Cancer, Brazil
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- January 17, 2025
- Completion date
- January 7, 2026
- Enrollment
- 0 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
oral mucositis, oral mucositis (ulcerative) due to antineoplastic therapy, oral mucositis (ulcerative) due to radiation, oral mucositis due to radiation